AMBER is Science Foundation Ireland’s Advanced Materials and BioEngineering Research Centre. It is one of the key drivers of Ireland’s growing international research reputation and this video celebrates our first year of research outputs. Ireland has been ranked 3rd in the world for nanoscience and 6th in the world for the quality of materials science research.

Since our launch in late 2013, researchers at AMBER have announced four world first discoveries in the areas of materials science which have been internationally recognised. Materials science is one of the fastest growing sectors globally, impacting electronics, medical technologies, and pharmaceuticals. Ireland exports approximately €80 billion worth of these products annually.

Key milestones include:

(1) 21 companies working with us on 31 targeted projects

(2) 3 collaborating universities

(3) Over 300 publications

(4) 7 licenses to companies

(5) Securing over €7m in European funding and €3.5m from industry

Europe’s Graphene Flagship lays out a science and technology road map, targeting research areas designed to take graphene and related 2d materials from academic laboratories into society. In October 2013, academia and industry came together to form the Graphene Flagship. Now with 142 partners in 23 countries, and a growing number of associate members, the Graphene Flagship was established following a call from the European Commission to address big science and technology challenges of the day through long-term, multidisciplinary R&D efforts.

In an open-access paper published today in the Royal Society of Chemistry journal Nanoscale, more than 60 academics and industrialists lay out a science and technology roadmap for graphene, related two-dimensional crystals, other 2d materials, and hybrid systems based on a combination of different 2d crystals and other nanomaterials. The roadmap covers the next 10 years and beyond, and its objective is to guide the research community and industry toward the development of products based on graphene and related materials.

More details can be found at:

A Multidisciplinary team at Trinity College Dublin from the School of Medicine and CRANN, the Science Foundation Ireland funded nanoscience institute, has developed a new screening approach to test the safety of nanomaterials and their effects on human cells. This research, which will have a significant impact across the many industries that utilise nanotechnology, was published in leading Scientific Reports (Nature Publishing Group) earlier this year.

CRANN researchers Professor Yuri Volkov and Dr. Adriele Prina-Mello and their team focused on the citrullination reaction, a post-translational modification of the amino acid arginine from its normal status in proteins into the amino acid citrulline. Citrulline, in turn, is a molecule which can cause inflammation in the body.

More information can be fund at: